PERRY ANDREW (Chief Commercial Officer) received a stock award from G1 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/3/2024ACC: 0001562180-24-005608
Officer· Chief Commercial Officer
Since Aug 2021
+35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
44.3%
7/1/2024
78.95K→113.95K
Total
Net shares
+35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2024 | A · Award | +35K | — | — | 44.3% | 78.95K | 113.95K |
| Total | +35K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported